Metabolomics Market - Top Companies and Manufacturers

  • Report ID: 515
  • Published Date: Jul 22, 2024
  • Report Format: PDF, PPT

Companies Dominating the Metabolomics Landscape

top-features-companies
    • Thermo Fisher Scientific
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Agilent Technologies
    • Biocrates Life Sciences AG
    • Bio-Rad Laboratories, Inc.
    • Bruker
    • Danaher
    • Human Metabolome Technologies America Inc.
    • LECO Corporation
    • Metabolon, Inc.
    • Shimadzu Corporation

Browse Key Market Insights with Data Illustration:

In the News

  • Thermo Fischer Scientific in association with UC Davis launched a Center of Excellence in Clinical Metabolomics, a research collaboration to provide the metabolomics community with innovations that will develop standardized processes for the research community, optimized liquid chromatography-mass spectrometry (LC-MS) methods to support the rapid scale-up of large cohort studies.

  • Agilent Technologies announced a new range of products designed to increase capabilities for food testing, environmental screening, and metabolomics research to provide enhanced analytical and business outcomes for laboratories.


Author Credits:  Radhika Pawar


  • Report ID: 515
  • Published Date: Jul 22, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of metabolomics is evaluated at USD 2.53 Billion.

The metabolomics market size was over USD 2.26 Billion in 2023 and is projected to reach USD 11.21 Billion by the end of 2036, growing at around 13.1% CAGR during the forecast period i.e., between 2024-2036. Growing acceptance of metabolomics in personalized medicine, increased incidence of chronic diseases, funding from government and private authorities are the major factors driving the market growth.

Asia Pacific is anticipated to dominate majority industry share by 2036, on the back of increasing demand for pharmaceutical and biopharmaceutical products developed in the regions of developing countries such as India and China.

Thermo Fisher Scientific, Agilent Technologies, Biocrates Life Sciences AG, Bio-Rad Laboratories, Inc., Bruker, Danaher, Human Metabolome Technologies America Inc., LECO Corporation, Metabolon, Inc., Shimadzu Corporation
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying